AMICOSANTE, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 10.383
AS - Asia 6.078
EU - Europa 5.362
SA - Sud America 826
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 15
Totale 22.780
Nazione #
US - Stati Uniti d'America 10.269
SG - Singapore 2.613
IE - Irlanda 1.460
CN - Cina 1.358
TR - Turchia 887
DE - Germania 731
BR - Brasile 727
HK - Hong Kong 645
RU - Federazione Russa 559
GB - Regno Unito 512
IT - Italia 474
UA - Ucraina 436
SE - Svezia 419
FI - Finlandia 287
FR - Francia 218
VN - Vietnam 168
IN - India 112
NL - Olanda 64
CA - Canada 59
JP - Giappone 58
BE - Belgio 43
BD - Bangladesh 42
MX - Messico 36
PL - Polonia 34
ZA - Sudafrica 34
AR - Argentina 33
ES - Italia 32
ID - Indonesia 30
IQ - Iraq 30
KR - Corea 22
EU - Europa 20
MA - Marocco 18
UZ - Uzbekistan 17
LT - Lituania 16
VE - Venezuela 16
CZ - Repubblica Ceca 15
RO - Romania 15
CO - Colombia 14
EC - Ecuador 14
PK - Pakistan 12
AU - Australia 11
DZ - Algeria 9
IL - Israele 9
NP - Nepal 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 7
CH - Svizzera 7
DK - Danimarca 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
OM - Oman 7
PY - Paraguay 7
KG - Kirghizistan 6
MD - Moldavia 6
AT - Austria 5
HU - Ungheria 5
IR - Iran 5
JM - Giamaica 5
TN - Tunisia 5
AL - Albania 4
PE - Perù 4
AO - Angola 3
CL - Cile 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
PH - Filippine 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GN - Guinea 1
GY - Guiana 1
HT - Haiti 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
Totale 22.771
Città #
Jacksonville 1.716
Chandler 1.463
Dublin 1.460
Singapore 1.460
Dallas 1.222
Hong Kong 642
Santa Clara 545
Boardman 502
Izmir 489
Ashburn 435
Nanjing 313
Ann Arbor 284
Wilmington 248
Lawrence 228
Princeton 228
The Dalles 225
New York 203
Seattle 186
Columbus 154
Beijing 147
Moscow 143
San Mateo 127
Milan 119
Nanchang 117
Los Angeles 98
Munich 83
Woodbridge 82
L'aquila 76
Mountain View 76
Bremen 74
São Paulo 69
Council Bluffs 68
Tianjin 65
Shenyang 63
San Jose 58
Hebei 57
Tokyo 57
Düsseldorf 52
Verona 52
Ho Chi Minh City 47
Kunming 47
Jiaxing 44
Jinan 44
Brussels 42
Turku 42
Dong Ket 41
Helsinki 40
Hefei 39
Dearborn 34
Des Moines 34
Warsaw 33
Denver 32
Fremont 31
Norwalk 31
Rome 31
Shanghai 31
Changsha 30
Rio de Janeiro 29
Hanoi 28
Falls Church 27
Houston 27
Zhengzhou 27
Belo Horizonte 25
Jakarta 25
Orem 25
Lanzhou 24
San Francisco 22
Brooklyn 21
Guangzhou 21
Ningbo 21
Seoul 21
Brasília 20
Johannesburg 20
Montreal 20
Amsterdam 19
Atlanta 19
Chennai 19
L’Aquila 18
Stockholm 18
Falkenstein 17
Poplar 17
Changchun 15
Chicago 15
London 15
Tashkent 15
Toronto 15
Frankfurt am Main 14
Ankara 12
Baghdad 12
Istanbul 12
Manchester 12
Philadelphia 12
Phoenix 12
Pelotas 11
Boston 10
Brno 10
Curitiba 10
Dhaka 10
Pune 10
Tappahannock 10
Totale 15.121
Nome #
OXA-23 Carbapenemase in Multidrug-Resistant Acinetobacter baumannii ST2 Type: First Identification in L'Aquila Hospital (Italy) 181
Ceftibuten stability to active-site serine and metallo-ß-lactamases 168
SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein 165
Ceftaroline in vitro activity against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci: a short report from Italy 158
Broad spectrum β-lactamases of citrobacter diversus 156
The 1.5-Å structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril 155
In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and Delta E model methods 154
CTX and its desacetyl derivative (des-CTX): Interaction with some representative β-lactamases and their related pattern of resistance to newer selected clinical isolates 154
Evaluations of the effects of extremely low-frequency electromagnetic fields on growth and antibiotic susceptibility of escherichia coli and pseudomonas aeruginosa 151
Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location 144
In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates 144
A class-A β-lactamase from Pseudomonas stutzeri that is highly active against monobactams and cefotaxime 143
Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species 141
Beta-lactamase of Mycobacterium fortuitum: Introduction to the problem and first experimental data on purification and characterization 140
Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex β-lactamase patterns including extended-spectrum enzymes 139
First Identification of β-Lactamases in Antibiotic-Resistant Escherichia coli, Citrobacter freundii, and Aeromonas spp. Isolated in Stream Macroinvertebrates in a Central Italian Region. 139
Inhibition of the transcriptional repressor LexA: Withstanding drug resistance by inhibiting the bacterial mechanisms of adaptation to antimicrobials 138
Replacement R164H and V240H by site-directed mutagenesis of TEM-149 ESBL: kinetic analysis of TEM-149H240 and TEM-149H164-H240 laboratory mutants 136
Use of chromatofocusing in purification of proteins 135
Interaction of neomycin with human erythrocytes 134
Anti-apoptotic and anti-inflammatory activity of Gentiana lutea root extract 134
Interaction between antimicrobial peptides (AMPs) and their primary target, the biomembranes 133
Kinetic Study of the Effect of Histidines 240 and 164 on TEM-149 Enzyme Probed by β-Lactam Inhibitors. 132
Characterization of a β-lactamase produced in Mycobacterium fortuitum D316 132
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals 131
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates 131
Derivative spectroscopy as a nonperturbative tool to detect the state of liposome-entrapped sulbactam 130
β-lactamase of Mycobacterium fortuitum: Kinetics of production and relationship with resistance to β-lactam antibiotics 130
Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study 129
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease 129
Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1). 128
Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa 128
Cyclic and acyclic amine oxide alkyl derivatives as potential adjuvants in antimicrobial chemotherapy against methicillin-resistant staphylococcus aureus with an MDR profile 128
Rapid characterization and partial purification of various animal amine oxidases 127
BlaB-15, a new BlaB metallo-β-lactamase variant found in an Elizabethkingia miricola clinical isolate 127
Citrobacter diversus ULA27 produces two forms of a chromosomal β-lactamase 127
Interactions of biapenem with active-site serine and metallo-β-lactamases 127
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten 126
Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey 125
Interaction of carbapenems and β-lactamase inhibitors towards CTX-M-15 and CTX-M-15G238Cmutant 125
Amino acid replacement at position 228 induces fluctuation in the Ω-loop of KPC-3 and reduces the affinity against oxyimino cephalosporins: Kinetic and molecular dynamics studies 125
β-Lactamases as major mechanism of resi stance in Gram-negative bacteria. 124
Identification of new natural CphA metallo-β-lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from municipal sewage in central Italy 124
Extremely low frequency (ELF) electromagnetic field (EMF) reduces quercetin-induced apoptosis in K562 cells: possible role of HSP-70 124
Cloning and nucleotide sequencing of the gene encoding the ß-lactamase from Citrobacter diversus 123
Influence of L-carnitine on CD95 cross-linking-induced apoptosis and ceramide generation in human cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases in vitro 122
Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro 121
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum β-lactamase genes cloned from a natural isolate and a high-level β-lactamase producer 121
Emergence of blaKPC-3-Tn4401a in Klebsiella pneumoniae ST512 in the municipal wastewater treatment plant and in the university hospital of a town in central Italy. 120
Fractionation and characterization of two β-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing 120
Exploring the role of l10 loop in new delhi metallo-β-lactamase (Ndm-1): Kinetic and dynamic studies 120
QnrB9 in association with TEM-116 extended-spectrum beta-lactamase in Citrobacter freundii isolated from sewage effluent: first report from Italy 119
Kinetic studies on CphA mutants reveal the role of the P158-P172 loop in activity versus carbapenems 119
In vitro activity of cefodizime (HR-221) in combination with β-lactamase inhibitors 119
Kinetic profile and molecular dynamic studies show that Y229W substitution in an NDM-1/L209F variant restores the hydrolytic activity of the enzyme toward penicillins, cephalosporins, and carbapenems 119
Ceftazidime and aztreonam resistance in Providencia stuartii: Characterization of a natural TEM-derived extended-spectrum β-lactamase, TEM-60 117
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum β-lactamase expressed in Escherichia coli 117
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 117
Effects of extracts from lactic acid bacteria on tumor cell invasiveness in vitro 116
Meropenem stability to β-lactamase hydrolysis and comparative in vitro activity against several β-lactamase-producing Gram-negative strains 116
Novel TEM-type extended-spectrum β-lactamase, TEM-134, in a Citrobacter koseri clinical isolate 116
Interaction between lichen secondary metabolites and antibiotics against clinical isolates methicillin-resistant staphylococcus aureus strains. 115
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital 115
Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain 115
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: Analysis of the quinolone resistance acquisition 115
Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase 115
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales 115
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase 114
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary University hospital of Verona (Northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases. 114
P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency towards carbapenems. 114
Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities 112
A new metallo-beta-lactamase gene (blaIMP-22) harboured in class 1 integron from Pseudomonas fluorescens 112
Characterization of the chromosomal cephalosporinases produced by Acinetobacter Iwoffii and Acinetobacter baumannii clinical isolates 111
Dynamical aspects of TEM-1 β-Lactamase probed by molecular dynamics 111
CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem 110
Curcumin inhibits the SOS response induced by levofloxacin in Escherichia coli 109
Kinetic study of laboratory mutants of NDM-1 metallo-β-lactamase and the importance of an isoleucine at position 35 109
High specificity of cphA-encoded metallo-β-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to β-lactam resistance 109
β-Lactamase induction antagonizes β-lactam susceptibilities in Citrobacter diversus and Enterobacter cloacae clinical isolates 109
Leucocianidine e collagenasi: inibizione dell’attività enzimatica “in vitro” 108
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. 107
On the kinetic interaction between ceftriaxone and some β-lactamases 107
Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production 106
Natural D240G Toho1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43 106
Biochemical characterization of TEM-92 extended-spectrum β-lactamase, a protein differing from TEM-52 in the signal peptide 106
Decreased production of AmpC-type β-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains 106
Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry 105
Infections with VIM-1 metallo-β-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome 105
Antibacterial activity of selected metabolites from Chilean lichen species against methicillin-resistant staphylococci 105
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators 105
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region 104
Laboratory variants GESG170L, GESG170K, and GESG170H increase carbapenem hydrolysis and confer resistance to clavulanic acid 104
Photohemolysis of erythrocytes enriched with superoxide dismutase, catalase and glutathione peroxidase 103
Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny 103
Use of the chromosomal class A β-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory β-lactam compounds 103
Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli 103
Photodynamic damage induced by bilirubin on human platelets: possible relevance to newborn pathology 102
Nimesulide e Collagenasi: inibizione dell'attività enzimatica "in vitro" 102
Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class a β- lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases 102
Beta-lactamase activity of Mycobacterium fortuitum 102
Totale 12.291
Categoria #
all - tutte 99.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.217 0 0 0 0 0 54 465 18 236 56 304 84
2021/20221.507 55 70 149 68 61 29 42 308 82 65 92 486
2022/20234.293 314 245 56 463 457 406 2 260 1.899 21 108 62
2023/2024867 143 69 77 91 72 213 21 69 8 25 25 54
2024/20254.856 89 69 415 256 743 483 670 466 876 178 422 189
2025/20264.791 441 890 969 958 902 631 0 0 0 0 0 0
Totale 23.594